Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transfer RNA (tRNA) anticodon stem-loop (ASL) is a fundamental structural component of tRNA molecules, essential for the accurate translation of mRNA into polypeptides. It consists of a seven-nucleotide loop containing the anticodon triplet, supported by a five-base-pair stem. The ASL's primary biological function is to recognize and bind to complementary mRNA codons within the ribosome's decoding center, a process heavily influenced by post-transcriptional modifications that enhance binding affinity and specificity (Agris et al., 2017). In clinical medicine, the ASL-ribosome interface is a major target for aminoglycoside antibiotics, which bind to the 16S rRNA and alter the conformation of the decoding site to favor the acceptance of near-cognate tRNA ASLs, resulting in lethal mistranslation in bacteria (Vicens & Westhof, 2003). Beyond infectious diseases, mutations in the ASL of mitochondrial tRNAs are implicated in severe metabolic disorders like MELAS, while aberrant ASL modification patterns are increasingly recognized as drivers of oncogenesis and neurological decline (Suzuki, 2021). Consequently, the ASL represents a sophisticated target for both traditional antimicrobial agents and emerging RNA-based precision therapies.
Stabilization of the codon-anticodon interaction at the ribosomal A-site, leading to misreading of the genetic code and inhibition of protein synthesis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transfer RNA anticodon stem-loop (tRNA ASL).